Pharmaceutics International, Inc., a pharmaceutical company, recently filed a notice with the New Hampshire Attorney General regarding a data breach. The report, submitted on December 22, 2025, indicates that an incident occurred where the personal information of some individuals may have been accessed without authorization.
While the specific categories of data involved have not been detailed, the breach could potentially expose affected individuals to various risks. When your personal information is compromised, it can open the door to identity theft, financial fraud, and other malicious activities by cybercriminals.
Anyone who received a data breach notification letter from Pharmaceutics International, Inc. should take immediate steps to protect themselves. It is advisable to carefully review the notification letter for any specific guidance provided. You should also consider monitoring your financial accounts and credit reports for any suspicious activity.
Setting up fraud alerts with credit bureaus can add an extra layer of protection, making it harder for unauthorized parties to open new accounts in your name. Additionally, be wary of unexpected emails, calls, or texts, as scammers may try to use the exposed information to impersonate legitimate organizations and trick you into revealing more data.
Currently, the breach is under investigation to determine the full extent of the incident and how it occurred. In many cases like this, individuals whose data was compromised may have legal recourse through a class action lawsuit to seek compensation for damages and losses incurred due to the breach.
If you received a data breach notification letter from Pharmaceutics International, Inc., it's important to understand your rights. We are investigating whether a class action lawsuit is appropriate given the circumstances of this data compromise. Contact us for a free, no-obligation case review to discuss your situation and potential legal options.